Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18617779rdf:typepubmed:Citationlld:pubmed
pubmed-article:18617779lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:18617779lifeskim:mentionsumls-concept:C0012634lld:lifeskim
pubmed-article:18617779lifeskim:mentionsumls-concept:C0010346lld:lifeskim
pubmed-article:18617779lifeskim:mentionsumls-concept:C0004927lld:lifeskim
pubmed-article:18617779lifeskim:mentionsumls-concept:C1439296lld:lifeskim
pubmed-article:18617779lifeskim:mentionsumls-concept:C0332281lld:lifeskim
pubmed-article:18617779lifeskim:mentionsumls-concept:C1882417lld:lifeskim
pubmed-article:18617779pubmed:issue8lld:pubmed
pubmed-article:18617779pubmed:dateCreated2008-7-11lld:pubmed
pubmed-article:18617779pubmed:abstractTextCX3CR1, the receptor of CX3CL1/fractalkine, is involved in regulation of inflammatory response and the CX3CR1-I249-M280 naturally occurring mutants are associated with altered binding to the ligand. Our aim was to evaluate the frequency of CX3CR1 V249I and T280M polymorphisms and NOD2/CARD15 mutations in Crohn's disease patients and to search for a relationship with phenotype.lld:pubmed
pubmed-article:18617779pubmed:languageenglld:pubmed
pubmed-article:18617779pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18617779pubmed:citationSubsetIMlld:pubmed
pubmed-article:18617779pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18617779pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18617779pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18617779pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18617779pubmed:statusMEDLINElld:pubmed
pubmed-article:18617779pubmed:monthAuglld:pubmed
pubmed-article:18617779pubmed:issn0954-691Xlld:pubmed
pubmed-article:18617779pubmed:authorpubmed-author:DeybachJean-C...lld:pubmed
pubmed-article:18617779pubmed:authorpubmed-author:SobhaniIradjIlld:pubmed
pubmed-article:18617779pubmed:authorpubmed-author:SouléJean-Cla...lld:pubmed
pubmed-article:18617779pubmed:authorpubmed-author:CoffinBenoitBlld:pubmed
pubmed-article:18617779pubmed:authorpubmed-author:JianRaymondRlld:pubmed
pubmed-article:18617779pubmed:authorpubmed-author:AmezianeNejma...lld:pubmed
pubmed-article:18617779pubmed:authorpubmed-author:de...lld:pubmed
pubmed-article:18617779pubmed:authorpubmed-author:FarmachidiJea...lld:pubmed
pubmed-article:18617779pubmed:authorpubmed-author:LamorilJérôme...lld:pubmed
pubmed-article:18617779pubmed:authorpubmed-author:SabateJean-Ma...lld:pubmed
pubmed-article:18617779pubmed:authorpubmed-author:JouetPaulinePlld:pubmed
pubmed-article:18617779pubmed:authorpubmed-author:HarnoisFloren...lld:pubmed
pubmed-article:18617779pubmed:issnTypePrintlld:pubmed
pubmed-article:18617779pubmed:volume20lld:pubmed
pubmed-article:18617779pubmed:ownerNLMlld:pubmed
pubmed-article:18617779pubmed:authorsCompleteYlld:pubmed
pubmed-article:18617779pubmed:pagination748-55lld:pubmed
pubmed-article:18617779pubmed:dateRevised2009-10-16lld:pubmed
pubmed-article:18617779pubmed:meshHeadingpubmed-meshheading:18617779...lld:pubmed
pubmed-article:18617779pubmed:meshHeadingpubmed-meshheading:18617779...lld:pubmed
pubmed-article:18617779pubmed:meshHeadingpubmed-meshheading:18617779...lld:pubmed
pubmed-article:18617779pubmed:meshHeadingpubmed-meshheading:18617779...lld:pubmed
pubmed-article:18617779pubmed:meshHeadingpubmed-meshheading:18617779...lld:pubmed
pubmed-article:18617779pubmed:meshHeadingpubmed-meshheading:18617779...lld:pubmed
pubmed-article:18617779pubmed:meshHeadingpubmed-meshheading:18617779...lld:pubmed
pubmed-article:18617779pubmed:meshHeadingpubmed-meshheading:18617779...lld:pubmed
pubmed-article:18617779pubmed:meshHeadingpubmed-meshheading:18617779...lld:pubmed
pubmed-article:18617779pubmed:meshHeadingpubmed-meshheading:18617779...lld:pubmed
pubmed-article:18617779pubmed:meshHeadingpubmed-meshheading:18617779...lld:pubmed
pubmed-article:18617779pubmed:meshHeadingpubmed-meshheading:18617779...lld:pubmed
pubmed-article:18617779pubmed:meshHeadingpubmed-meshheading:18617779...lld:pubmed
pubmed-article:18617779pubmed:meshHeadingpubmed-meshheading:18617779...lld:pubmed
pubmed-article:18617779pubmed:meshHeadingpubmed-meshheading:18617779...lld:pubmed
pubmed-article:18617779pubmed:meshHeadingpubmed-meshheading:18617779...lld:pubmed
pubmed-article:18617779pubmed:meshHeadingpubmed-meshheading:18617779...lld:pubmed
pubmed-article:18617779pubmed:meshHeadingpubmed-meshheading:18617779...lld:pubmed
pubmed-article:18617779pubmed:year2008lld:pubmed
pubmed-article:18617779pubmed:articleTitleThe V249I polymorphism of the CX3CR1 gene is associated with fibrostenotic disease behavior in patients with Crohn's disease.lld:pubmed
pubmed-article:18617779pubmed:affiliationDepartment of Gastroenterology and Hepatology, AP-HP, Louis Mourier Hospital, Colombes, France.lld:pubmed
pubmed-article:18617779pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18617779pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:18617779pubmed:publicationTypeMulticenter Studylld:pubmed
entrez-gene:1524entrezgene:pubmedpubmed-article:18617779lld:entrezgene
entrez-gene:64127entrezgene:pubmedpubmed-article:18617779lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18617779lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18617779lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18617779lld:entrezgene
lhgdn:association:32162lhgdn:found_inpubmed-article:18617779lld:lhgdn
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18617779lld:pubmed